Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration.

[1]  Zhiqing Yuan,et al.  Role of farnesoid X receptor in cholestasis , 2016, Journal of digestive diseases.

[2]  C. Endres,et al.  The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse , 2016, Biopharmaceutics & drug disposition.

[3]  K. Miyamoto,et al.  Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2. , 2015, Journal of pharmaceutical sciences.

[4]  Hyunyoung Jeong,et al.  GW4064, an Agonist of Farnesoid X Receptor, Represses CYP3A4 Expression in Human Hepatocytes by Inducing Small Heterodimer Partner Expression , 2015, Drug Metabolism and Disposition.

[5]  T. Terasaki,et al.  Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset. , 2013, Journal of pharmaceutical sciences.

[6]  S-M Huang,et al.  Transporters in Drug Development and Clinical Pharmacology , 2013, Clinical pharmacology and therapeutics.

[7]  T. Terasaki,et al.  A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice , 2013, Fluids and Barriers of the CNS.

[8]  S. Amin,et al.  Elevated hepatic iron activates NF-E2-related factor 2-regulated pathway in a dietary iron overload mouse model. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  I. Wittig,et al.  Protein S-nitrosylation and denitrosylation in the mouse spinal cord upon injury of the sciatic nerve. , 2012, Journal of proteomics.

[10]  C. Klaassen,et al.  Effect of Graded Nrf2 Activation on Phase-I and -II Drug Metabolizing Enzymes and Transporters in Mouse Liver , 2012, PloS one.

[11]  J. Prieto,et al.  Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice. , 2012, Journal of hepatology.

[12]  N. Kato,et al.  ENT1, a Ribavirin Transporter, Plays a Pivotal Role in Antiviral Efficacy of Ribavirin in a Hepatitis C Virus Replication Cell System , 2012, Antimicrobial Agents and Chemotherapy.

[13]  Tetsuya Terasaki,et al.  Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities , 2012, Drug Metabolism and Disposition.

[14]  Tetsuya Terasaki,et al.  Reliability and robustness of simultaneous absolute quantification of drug transporters, cytochrome P450 enzymes, and Udp-glucuronosyltransferases in human liver tissue by multiplexed MRM/selected reaction monitoring mode tandem mass spectrometry with nano-liquid chromatography. , 2011, Journal of pharmaceutical sciences.

[15]  Z. Meng,et al.  Nuclear bile acid receptor FXR in the hepatic regeneration. , 2011, Biochimica et biophysica acta.

[16]  G. Kullak-Ublick,et al.  Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. , 2011, Journal of hepatology.

[17]  M. Suematsu,et al.  4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. , 2010, Journal of molecular and cellular cardiology.

[18]  P. Dawson,et al.  Bile acid transporters , 2009, Journal of Lipid Research.

[19]  C. Klaassen,et al.  Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[20]  O. van Tellingen,et al.  Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo , 2009, Clinical Cancer Research.

[21]  B. Halliwell,et al.  Elevated oxidative stress, iron accumulation around microvessels and increased 4-hydroxynonenal immunostaining in zone 1 of the liver acinus in hypercholesterolemic rabbits , 2009, Free radical research.

[22]  Yi Wang,et al.  Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin , 2008, Drug Metabolism and Disposition.

[23]  T. Pfammatter,et al.  Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver , 2008, Hepatology.

[24]  Tetsuya Terasaki,et al.  Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria , 2008, Pharmaceutical Research.

[25]  Yuichi Sugiyama,et al.  Involvement of Breast Cancer Resistance Protein (ABCG2) in the Biliary Excretion Mechanism of Fluoroquinolones , 2007, Drug Metabolism and Disposition.

[26]  C. Klaassen,et al.  Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. , 2007, Biochimica et biophysica acta.

[27]  D. Moore,et al.  Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration , 2006, Science.

[28]  P. Faybik,et al.  Plasma disappearance rate of indocyanine green in liver dysfunction. , 2006, Transplantation proceedings.

[29]  Xingguo Cheng,et al.  REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDES (OATPS) IN LIVER BY PROTOTYPICAL MICROSOMAL ENZYME INDUCERS THAT ACTIVATE DISTINCT TRANSCRIPTION FACTOR PATHWAYS , 2005, Drug Metabolism and Disposition.

[30]  A. V. van Herwaarden,et al.  The Breast Cancer Resistance Protein (BCRP/ABCG2) Affects Pharmacokinetics, Hepatobiliary Excretion, and Milk Secretion of the Antibiotic Nitrofurantoin , 2005, Molecular Pharmacology.

[31]  U. Meyer,et al.  Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. , 2004, Pharmacogenetics.

[32]  K. Zatloukal,et al.  Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. , 2003, Journal of hepatology.

[33]  M. Shibata,et al.  Massive apoptotic cell death in chemically induced rat urinary bladder carcinomas following in situ HSVtk electrogene transfer , 2003, The journal of gene medicine.

[34]  Zhe-Sheng Chen,et al.  Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). , 2002, Cancer research.

[35]  Masao Tanaka,et al.  Lack of intestinal bile results in delayed liver regeneration of normal rat liver after hepatectomy accompanied by impaired cyclin E-associated kinase activity. , 2002, Surgery.

[36]  F. Lammert,et al.  Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. , 2001, Gastroenterology.

[37]  M. J. van de Vijver,et al.  Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. , 2001, Cancer research.

[38]  Heping Yang,et al.  Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[40]  P. Meier,et al.  Transport function and hepatocellular localization of mrp6 in rat liver. , 2000, Molecular pharmacology.

[41]  P. Meier,et al.  Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. , 1999, Gastroenterology.

[42]  C. Bréchot,et al.  Cell lineage study in the liver using retroviral mediated gene transfer. Evidence against the streaming of hepatocytes in normal liver. , 1994, The American journal of pathology.

[43]  Y. Nimura,et al.  Decrease in regeneration capacity of rat liver after external biliary drainage. , 1992, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[44]  F. Mashige,et al.  Direct spectrophotometry of total bile acids in serum. , 1981, Clinical chemistry.

[45]  T. Terasaki,et al.  Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism Correlation of Organic Cation/Carnitine Transporter 1 and Multidrug Resistance-Associated Protein 1 Transport Activities With Protein Expression Levels in Primary Cultured Human Tracheal, Bronchial, and Alveolar Epithelial Cells , 2016 .

[46]  Tetsuya Terasaki,et al.  Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection. , 2011, Journal of pharmaceutical sciences.

[47]  B. Staels,et al.  Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.

[48]  J. Ellen.  Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats , 2002 .